INHIBITORS AND ACTIVATORS OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE.CHASIN M; HARRIS DN.1976; ADV. CYCL. NUCLEOT. RES.; U.S.A.; DA. 1976; VOL. 7; PP. 225-264; BIBL. 13 P.Article

HYPOTENSION INDUCED BY INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME IN PENTOBARBITAL-ANESTHETIZED DOGSVOLLMER RR; BOCCAGNO JA; HARRIS DN et al.1978; EUROP. J. PHARMACOL.; NLD; DA. 1978; VOL. 51; NO 1; PP. 39-45; BIBL. 21 REF.Article

INHIBITION OF ADENYLATE CYCLASE IN HUMAN BLOOD PLATELETS BY 9-SUBSTITUTED ADENINE DERIVATIVESHARRIS DN; ASAAD MM; PHILLIPS MB et al.1979; J. CYCL. NUCLEOT. RES.; USA; DA. 1979; VOL. 5; NO 2; PP. 125-134; BIBL. 38 REF.Article

1-ETHYL-4-(ISOPROPYLIDENEHYDRAZINO)-1H-PYRAZOLO - (3,4-B) - PYRIDINE-5-CARBOXYLIC ACID, ETHYL ESTER, HYDROCHLORIDE (SQ 20009). A PATENT NEW INHIBITOR OF CYCLIC 3,5-NUCLEOTIDE PHOSPHODIESTERASES = LE CHLORHYDRATE DE L'ESTER ETHYLIQUE DE L'ACIDE ETHYL-1 (ISOPROPYLIDENEHYDRAZINO)-4 1H-PYRAZOLO(3,4-B) PYRIDINE CARBOXYLIQUE-5 (SQ20009) UN NOUVEL INHIBITEUR PUISSANT DE LA PHOSPHODIESTERASE DES NUCLEOTIDES-3,5 CYCLIQUESCHASIN M; HARRIS DN; PHILLIPS MB et al.1972; BIOCHEM. PHARMACOL.; G.B.; DA. 1972; VOL. 21; NO 18; PP. 2443-2450; BIBL. 30REF.Serial Issue

CHRONIC ANTIHYPERTENSIVE EFFECTS OF CAPTOPRIL (SQ 14,225), AN ORALLY ACTIVE ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR, IN CONSCIOUS 2-KIDNEY RENAL HYPERTENSIVE RATSRUBIN B; ANTONACCIO MJ; GOLDBERG ME et al.1978; EUROP. J. PHARMACOL.; NLD; DA. 1978; VOL. 51; NO 4; PP. 377-388; BIBL. 2 P.Article

EFFECT OF CYCLIC NUCLEOTIDES ON ACTIVITY OF CYCLIC 3PRIME ,5PRIME -ADENOSINE MONOPHOSPHATE PHOSPHODIESTERASE = EFFET DES NUCLEOTIDES CYCLIQUES SUR L'ACTIVITE DE LA 3PRIME ,5PRIME -ADENOSINE-MONOPHOSPHATE-CYCLIQUE-PHOSPHODIESTERASEHARRIS DN; CHASIM M; PHILLIPS MB et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 2; PP. 221-228; BIBL. 27REF.Article

EFFECTS OF SQ 14,225, AN ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME ON BLOOD PRESSURE, HEART RATE AND PLASMA RENIN ACTIVITY OF CONSCIOUS NORMOTENSIVE DOGSHARRIS DN; HERAN CL; GOLDENBERG HJ et al.1978; EUROP. J. PHARMACOL.; NLD; DA. 1978; VOL. 51; NO 4; PP. 345-349; BIBL. 23 REF.Article

SOME BIOCHEMICAL ACTIVITIES OF 10,10-DIFLUORO-13-DEHYDROPROSTACYCLIN, A CHEMICALLY STABLE ANALOG OF PROSTACYCLIN, IN HUMAN BLOOD PLATELETSHARRIS DN; PHILLIPS MB; MICHEL IM et al.1981; THROMB. RES.; ISSN 0049-3848; USA; DA. 1981; VOL. 23; NO 4-5; PP. 387-399; BIBL. 2 P.Article

9ALPHA -HOMO-9,11-EPOXY-5,13-PROSTADIENOIC ACID ANALOGUES: SPECIFIC STABLE AGONIST (SQ26,538) AND ANTAGONIST (SQ26,536) OF THE HUMAN PLATELET THROMBOXANE RECEPTORHARRIS DN; PHILLIPS MB; MICHEL IM et al.1981; PROSTAGLANDINS; ISSN 0090-6980; USA; DA. 1981; VOL. 22; NO 2; PP. 295-307; BIBL. 34 REF.Article

EFFECTS OF CHRONIC TREATMENT WITH CAPTOPRIL (SQ 14,225), AN ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN 1-CONVERTING ENZYME, IN SPONTANEOUSLY HYPERTENSIVE RATSANTANACCIO MJ; RUBIN B; HOROVITZ ZP et al.1979; JAP. J. PHARMACOL.; JPN; DA. 1979; VOL. 29; NO 2; PP. 285-294; BIBL. 23 REF.Article

EFFECTS OF THERAPEUTIC AGENTS ON CYCLIC AMP METABOLISM IN VITROWEINRYB I; CHASIN M; FREE CA et al.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1556-1567; BIBL. 56REF.Serial Issue